PRESS RELEASEEllex Medical Lasers Ltd (ASX:ELX)Adelaide,...

PRESS RELEASE
Ellex Medical Lasers Ltd (ASX:ELX)
Adelaide, Australia
Date: 23 April 2007
Release: Immediate
Topic: Ellex Gains US FDA Approval for 30XL Laser Slit Lamp
Adelaide, Australia, 23 April 2007 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and
manufacture of ophthalmic laser and ultrasound systems, announced today that it has gained US FDA 510(k)
approval to market the new Ellex 30XL™ laser slit lamp, which will be featured at the annual meeting of the American
Society of Cataract and Refractive Surgery (ASCRS) beginning April 27th, 2007 in San Diego, CA.
“FDA approval of the 30XL laser slit lamp represents another milestone in Ellex’s stated strategy to be the leading
brand of lasers to treat glaucoma, cataract and retinal conditions,” said Ellex CEO Peter Falzon. “Ellex has invested
$12 million over four years to expand our laser product line utilizing expertise gained as an OEM manufacturer of
over 12,000 laser systems since 1985.”
The 30XL laser slit lamp was designed for use in the ophthalmic clinic setting with the Ellex single or dual port
Solitaire green laser photocoagulator and Ellex laser indirect ophthalmoscope (LIO). Including the 30XL laser slit
lamp, Ellex provides the industry’s most complete line of lasers and accessories used by ophthalmologists to
preserve vision and fight blindness.
In addition, the Ellex ASCRS exhibit will feature booth presentations by Dr. Harvey Carter and Dr. Randy Craven on
advanced anterior segment laser and ultrasound procedures. And, for the first time, Ellex will exhibit and market the
Eye Cubed™ ultrasound system alongside their laser product line. The Eye Cubed ultrasound is being integrated
into Ellex’s product line following the December 2006 acquisition of Innovative Imaging Inc. of Sacramento,
California.